(Q64348559)
Statements
A Phase 1b, Double-blinded, Placebo-controlled, Randomized Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Doses Of Pf-06342674 (rn168) In Subjects With Multiple Sclerosis (ms) (English)
0 references
September 2014
0 references
October 2015
0 references
4
0 references
18 year
0 references
55 year
0 references